Cochrane Abstracts
Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Once Daily Long‐acting Beta2‐agonists and Long‐acting Muscarinic Antagonists in a Combined Inhaler Versus Placebo for Chronic Obstructive Pulmonary Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439866/all/Once_daily_long‐acting_beta2‐agonists_and_long‐acting_muscarinic_antagonists_in_a_combined_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease.
Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439866/all/Once_daily_long‐acting_beta2‐agonists_and_long‐acting_muscarinic_antagonists_in_a_combined_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease. Accessed April 28, 2025.
Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439866/all/Once_daily_long‐acting_beta2‐agonists_and_long‐acting_muscarinic_antagonists_in_a_combined_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease
Once Daily Long‐acting Beta2‐agonists and Long‐acting Muscarinic Antagonists in a Combined Inhaler Versus Placebo for Chronic Obstructive Pulmonary Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439866/all/Once_daily_long‐acting_beta2‐agonists_and_long‐acting_muscarinic_antagonists_in_a_combined_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease
ID - 439866
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439866/all/Once_daily_long‐acting_beta2‐agonists_and_long‐acting_muscarinic_antagonists_in_a_combined_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
